Ablation Map

An ablation map links each component of a method to the experiment that tests whether the component matters.

For a method with components $C = {c_{1}, \dots, c_{k}}$ , an ablation compares:

Δ_{i} = M (A_{full}) - M (A_{∖ c_{i}})

$M$ is the metric, $A_{full}$ is the full method, and $A_{∖ c_{i}}$ is the method with component $c_{i}$ removed or replaced.

What To Map

Component: architecture block, loss term, data source, feature, preprocessing step, or training trick.
Claim: what the paper says the component contributes.
Ablation: the experiment that isolates the component.
Metric: the number affected by the ablation.
Scope: whether the result holds across datasets, seeds, tasks, or model sizes.
Confounder: what else changed besides the component.

Use a table instead of prose-only ablation notes.

Component	Claimed role	Removal/replacement	Metric delta	Confounder	Verdict
architecture block	improves representation	remove block	$Δ_{i}$	parameter count changed	weak/medium/strong
loss term	stabilizes objective	set weight to zero	$Δ_{i}$	retuning missing	weak/medium/strong
data source	adds coverage	train without source	$Δ_{i}$	fewer samples	weak/medium/strong
preprocessing	removes noise	disable step	$Δ_{i}$	changes input distribution	weak/medium/strong

The verdict should be about evidence for the component, not whether the paper is good overall.

When the same seeds or splits are available, compare paired results:

d_{k} = M_{k} (A_{full}) - M_{k} (A_{∖ c_{i}})

Then inspect the mean and variance of $d_{k}$ , not only a single headline delta.

Does the ablation isolate one component?
Is the baseline strong enough without the component?
Are multiple seeds or confidence intervals reported?
Is the gain consistent across tasks or only one benchmark?
Does the ablation support a mechanism claim or only an empirical difference?
Are parameter count, training budget, data volume, and tuning budget controlled?
Is the ablation interpreted within the tested benchmark scope?